» Articles » PMID: 35063729

Predictors of Patient Post-discharge Opioid Use After Cesarean Delivery: a Prospective Study

Overview
Publisher Elsevier
Date 2022 Jan 22
PMID 35063729
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The opioid crisis is a public health emergency in the United States of America. It is important to understand factors associated with outpatient opioid use. Our primary aim was to assess post-cesarean outpatient opioid use. The secondary aim was to identify characteristics associated with use.

Methods: We conducted a prospective cohort analysis of women who underwent cesarean delivery at an urban academic center. Phone surveys were done on post-discharge days three, seven, and 14. The primary outcome was post-discharge opioid use.

Results: Of 205 eligible patients contacted, 190 (91%) agreed to participate and 173 (84%) participated in all three surveys. Median amount of opioid prescribed was 75 mg morphine equivalents (MME) (interquartile range 60-113) and participants used a median of 15 MME (0-53) by discharge day 14. Most patients (139/190) filled their opioid prescription but 42% (80/190) did not consume the opioids prescribed. Outpatient opioid use was associated with increased in-hospital opioid consumption (P=0.0003), gravidity (P=0.003), parity (P=0.004) and number of previous cesarean deliveries (P=0.02). Higher amounts of in-hospital opioid use (P=0.0004), higher gravidity (P=0.02), higher outpatient pain scores (>3/10, P=0.01), and poor pain control (P=0.04) were associated with consuming all prescribed opioids. Patients used opioids for a median of two days post-discharge. Use of non-opioid pain medication was not associated with opioid use.

Conclusion: Opioids were prescribed in excess of consumption and many patients did not use any opioids. Next steps include developing a prescribing algorithm to incorporate factors we found predictive of opioid use.

Citing Articles

Development of an implementation intervention to promote adoption of the COMFORT clinical practice guideline for peripartum pain management: a qualitative study.

Sharif L, Cocroft S, Smith S, Benincasa C, Peahl A, Low L Implement Sci Commun. 2025; 6(1):1.

PMID: 39748382 PMC: 11697899. DOI: 10.1186/s43058-024-00687-5.


Optimizing Opioid Prescription Quantity After Cesarean Delivery: A Randomized Controlled Trial.

Smid M, Clifton R, Rood K, Srinivas S, Simhan H, Casey B Obstet Gynecol. 2024; 144(2):195-205.

PMID: 38857509 PMC: 11257794. DOI: 10.1097/AOG.0000000000005649.


Brief Assessment of Patient Phenotype to Explain Variability in Postsurgical Pain and Opioid Consumption after Cesarean Delivery: Performance of a Novel Brief Questionnaire Compared to Long Questionnaires.

He J, Wilson J, Fields K, Zachos K, Franqueiro A, Reale S Anesthesiology. 2024; 140(4):701-714.

PMID: 38207329 PMC: 10939890. DOI: 10.1097/ALN.0000000000004900.